No results for ‘’
Medi Caps Ltd
₹26.75
(3.25%)
Wed, 24 Jun 2026, 05:55 pm
Health Technology
Pharmaceuticals: Major
24.5KMedi Caps Enterprise Value (EV)
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 4.02 | 2.14 | 1.44 | 2.05 | 6 | 6.46 | 10.66 | 0 | 0 | 0 | 29.64 | 25.09 | 25.05 | 3.83 | 0 | 4.52 | 6.14 | 24.81 | 0 | 0 |
| Price to book ratio | 0.84 | 0.46 | 0.40 | 0.14 | 0.38 | 0.29 | 0.18 | 0.22 | 0.16 | 0.21 | 0.31 | 0.39 | 0.32 | 0.22 | 0.11 | 0.48 | 0.53 | 0.37 | 0.46 | 0.43 |
| Price to sales ratio | 1.45 | 0.96 | 1.12 | 0.36 | 1.06 | 0.67 | 0.63 | 0.58 | 0.35 | 0.48 | 0.59 | 0.78 | 0.58 | 0.40 | 0.24 | 0.88 | 0.91 | 0.88 | 2.03 | 2.04 |
| Price to cash flow ratio | 3.56 | 1.97 | 1.57 | 1.34 | 5.16 | 6.64 | 2.06 | 0 | 0 | 2.48 | 9.85 | 8.56 | 6.85 | 3.46 | 2.20 | 3.28 | 8.82 | 0 | 7.96 | 10.20 |
| Enterprise value | 24.77Cr | 16.4Cr | 16.8Cr | 6.95Cr | 21.24Cr | 16.66Cr | 3.21Cr | 14.75Cr | 12.38Cr | 25.35Cr | 21.53Cr | 25.97Cr | 17.43Cr | 5.98Cr | -9.52Cr | 17.21Cr | 25.2Cr | 7.32Cr | 19.65Cr | 17.55Cr |
| Enterprise value to EBITDA ratio | 7.68 | 3.99 | 4.52 | 1.59 | 5.86 | 3.29 | 0.80 | 3.82 | 3.34 | 0 | 8.19 | 15.98 | 8.06 | 1.25 | 0 | 1.57 | 2.91 | 1.37 | 0 | 0 |
| Debt to equity ratio | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0.11 | 0.13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Return on equity % | 0 | 24.16 | 31.54 | 6.79 | 6.50 | 4.64 | 2.06 | -0.85 | -1.60 | -2.50 | 1.06 | 1.60 | 1.28 | 5.80 | -6.27 | 11.49 | 9.09 | 1.59 | -1.87 | -0.47 |
Medi Caps Ltd Enterprise Value
The Medi Caps Ltd Enterprise Value is a key financial metric used by investors to evaluate Medi Caps Ltd's valuation, profitability, and overall financial performance. Tracking the Medi Caps Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Medi Caps Ltd (NSE: MEDICAPS, BSE: 523144) is currently trading at ₹26.75, with a market capitalization of ₹34.39Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Medi Caps Ltd Enterprise Value is essential for fundamental analysis.
Medi Caps Ltd Enterprise Value Current Value
The current Medi Caps Ltd Enterprise Value stands at 17.55Cr.
The Medi Caps Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Medi Caps Ltd Enterprise Value Historical Trend
The Medi Caps Ltd Enterprise Value has shown the following historical trend:
- 2024: 17.55Cr
- 2023: 19.65Cr
- 2022: 7.32Cr
- 2021: 25.2Cr
- 2020: 17.21Cr
The decline in Medi Caps Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What Medi Caps Ltd Enterprise Value Indicates for Investors
The Medi Caps Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Medi Caps Ltd.
Medi Caps Ltd Enterprise Value Analysis Summary
The Medi Caps Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Medi Caps Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Medi Caps Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.